Dapa-Met XR Tablet 10mg / 1000mg

About Dapa-Met XR Tablet 10mg / 1000mg

Dapa-Met XR Tablet Uses

• Type 2 diabetes mellitus in adults not controlled on metformin or dapagliflozin alone
• Improving blood sugar control alongside diet and exercise
• Reducing risk of heart failure hospitalization in patients with type 2 diabetes
• Supporting kidney protection in adults with type 2 diabetes and chronic kidney disease

Dapa-Met XR Tablet Benefits

• Combines two complementary mechanisms in a single once daily tablet
• Extended release metformin reduces stomach upset compared to immediate release forms
• Lowers blood sugar while also supporting modest weight reduction
• Offers added cardiovascular and kidney benefits beyond glucose control
• Simplifies dosing schedule and may improve treatment adherence

What Experts Say

Endocrinologists prescribe dapagliflozin and metformin together because the two drugs lower blood sugar through different pathways. Metformin reduces liver glucose production and improves insulin sensitivity in muscle tissue. Dapagliflozin blocks glucose reabsorption in the kidney, so excess sugar leaves the body through urine instead of staying in the bloodstream.

This dual action allows physicians to achieve tighter glycemic control at doses that would cause more side effects if either drug were pushed higher alone. Clinical trial data also links dapagliflozin to reduced hospitalization for heart failure and slower decline in kidney function, which matters given how often type 2 diabetes in Pakistan coexists with hypertension and early kidney disease. The extended release metformin component is dosed once daily, which doctors often favor for patients who struggle with multiple daily doses.

Physicians typically start therapy only after confirming adequate kidney function, since both dapagliflozin and metformin depend on the kidneys for safe use. Regular monitoring of renal function and electrolytes remains part of standard follow up. Dose adjustments or temporary discontinuation are considered during illness, dehydration, or before procedures requiring contrast dye.

Drug Class

• SGLT2 inhibitor and biguanide combination
• Oral antidiabetic agent

Dapa-Met XR Tablet 10mg / 1000mg formula

• Dapagliflozin + Metformin Hydrochloride

Available forms

• Tablet 10mg / 1000mg

How to use Dapa-Met XR Tablet 10mg / 1000mg?

• Take one tablet by mouth once daily, usually in the morning with breakfast
• Swallow the tablet whole with a full glass of water
• Do not crush, split, or chew the tablet since this is an extended release formulation
• Take at the same time each day for consistent blood sugar control
• Continue diet and exercise recommendations given by your doctor
• Do not stop the medicine without consulting your doctor even if you feel well
• Missed doses should be taken as soon as remembered unless it is close to the next dose

Drug Interactions

• Insulin And Sulfonylureas: Combining with Dapa-Met XR increases the risk of low blood sugar and may require dose adjustment
• Diuretics: Water pills combined with dapagliflozin can worsen dehydration and lower blood pressure further
• Alcohol: Heavy or chronic alcohol use raises the risk of lactic acidosis with metformin and can worsen blood sugar control
• Iodinated Contrast Dye: Contrast agents used in imaging can impair kidney function and increase lactic acidosis risk with metformin
• Cimetidine: This acid reducing medicine can raise metformin levels in the blood by competing for kidney elimination
• Corticosteroids: Steroid medicines can raise blood sugar and reduce the effectiveness of Dapa-Met XR
• Diuretics And ACE Inhibitors Together: Combined use with dapagliflozin can increase the risk of kidney function decline in dehydrated patients
• Rifampicin: This antibiotic can reduce dapagliflozin levels through enzyme induction, potentially lowering its effect

Risks and warnings

• Genital Yeast Infections: Dapagliflozin increases sugar in urine, which raises the risk of vaginal yeast infections in women and balanitis in uncircumcised men
• Dehydration And Low Blood Pressure: Increased urination can lower blood volume, especially in elderly patients or those on diuretics
• Diabetic Ketoacidosis: A rare but serious risk even with normal or mildly elevated blood sugar, marked by nausea, vomiting, abdominal pain, and unusual tiredness
• Lactic Acidosis: A rare but life threatening metformin related risk that increases with kidney impairment, dehydration, heavy alcohol use, or severe infection
• Kidney Function Decline: Both components require adequate kidney function, and doses may need adjustment or discontinuation if kidney function worsens
• Urinary Tract Infections: Higher urinary glucose levels can increase susceptibility to bacterial urinary infections
• Fournier Gangrene: A rare but severe infection of the genital and perineal tissue reported with SGLT2 inhibitors, requiring urgent medical attention
• Bone Fracture Risk: Some studies link SGLT2 inhibitors to a modest increase in fracture risk with long term use
• Vitamin B12 Deficiency: Long term metformin use can lower vitamin B12 levels, so periodic monitoring is advised
• Surgery And Contrast Dye Precautions: Temporary discontinuation is usually recommended before surgery or imaging procedures involving iodinated contrast

Dapa-Met XR Tablet Side Effects

• Nausea or upset stomach
• Diarrhea
• Increased urination
• Vaginal yeast infection
• Urinary tract infection
• Headache
• Dizziness
• Low blood sugar when combined with insulin or sulfonylureas
• Back pain
• Fatigue
• Metallic taste in the mouth
• Dehydration
• Signs of ketoacidosis such as nausea, vomiting, and abdominal pain
• Signs of lactic acidosis such as muscle pain, difficulty breathing, and unusual tiredness

Storage Conditions

• Store below 30 degrees Celsius in a cool, dry place
• Keep the tablet in its original blister pack until ready to use
• Protect from moisture and direct sunlight
• Keep out of reach of children
• Do not use after the expiry date printed on the pack
• Do not store in the bathroom or near a kitchen sink